P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Interest Income Expense Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Interest Income Expense
â‚©13.8B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Interest Income Expense
-â‚©13B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Interest Income Expense
â‚©19.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Interest Income Expense
â‚©16.8B
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Interest Income Expense
â‚©8B
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Interest Income Expense
â‚©833m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Interest Income Expense?
Interest Income Expense
13.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Interest Income Expense amounts to 13.8B KRW.

What is PharmaResearch Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
53%

Over the last year, the Interest Income Expense growth was 1 337%. The average annual Interest Income Expense growth rates for PharmaResearch Co Ltd have been 53% over the past three years .

Back to Top